Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
Jia Huang,1 Yun Wang,1 Jun Chen,1 Yanlei Zhang,2 Zheng Yuan,2 Li Yue,2 Josep Maria Haro,3 Maria Victoria Moneta,3 Diego Novick,4 Yiru Fang1,5,6 1Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 2Medical Department, Eli Lil...
Enregistré dans:
Auteurs principaux: | Huang J, Wang Y, Chen J, Zhang Y, Yuan Z, Yue L, Haro JM, Moneta MV, Novick D, Fang YR |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bb7b29fd6d9e4e7ba39a12595ce76382 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
par: Novick D, et autres
Publié: (2016) -
Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
par: Kishi T, et autres
Publié: (2017) -
Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients
par: Novick D, et autres
Publié: (2016) -
Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
par: Maneeton B, et autres
Publié: (2018) -
Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder
par: Haider M, et autres
Publié: (2017)